












Jacob Borrajo
Founder
Jacob Borrajo was the founder of Coral Genomics which went through YC in S18. Coral integrates molecular, functional, and clinical factors to create new clinical laboratory tests that predict optimal treatments for autoimmune diseases. We have also identified a unique subpopulation of patients who do not respond to current therapies and are working towards addressing this unmet medical need.
Follow Jacob
Previously at

Scribio

MIT Media Lab

Broad Institute of MIT and Harvard

Harvard Medical School

UCLA

University of California, Los Angeles
Alumnus of

Massachusetts Institute of Technology

University of California, Los Angeles